SEATTLE — In this Healio Video Perspective from the ARVO meeting, Eric D. Donnenfeld, MD, discusses research that investigated Blink Triple Care artificial tears for the treatment of dry eye disease.According to Donnenfeld, Blink Triple Care drops (Bau…
MiDROPS® Achieves Pivotal Milestone: Proven Safe and Effective in Phase II Clinical Trial
OKLAHOMA CITY–(BUSINESS WIRE)–EyeCRO is thrilled to announce that groundbreaking data from the first clinical application of its innovative MiDROPS® platform technology is being presented by Telios Pharma at the 96th meeting of the Association for Re…
Qlaris raises $24 million for development of IOP-lowering therapy
Qlaris Bio raised $24 million during series B financing for the clinical development of QLS-111, a new IOP-lowering drug candidate for patients with glaucoma, the company announced in a press release.The financing was co-led by Canaan and New Leaf Vent…
VIDEO: Contact lens shows favorable vision, comfort outcomes across pupil sizes
SEATTLE — In this Healio Video Perspective from the ARVO meeting, William Reindel, OD, discusses the impact of pupil size on vision and comfort performance of a new multifocal daily disposable contact lens.The study included 293 subjects with presbyopi…
Woman presents with unilateral, painless vision loss
A 57-year-old woman was transferred to Lahey Hospital and Medical Center emergency department from a community hospital for an ophthalmology evaluation due to acute, painless vision loss in the left eye upon wakening that morning.The patient denied any…
With longer-acting therapies, is OCT monitoring advisable between injections?
Click here to read the Cover Story, “Experts weigh current, future options for AMD management.”Longer-acting drugs have been a great addition to our armamentarium.However, from the studies and our own experience, we have learned that they are not 100% …